Ozoroa insignis
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Ozoroa insignis |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Ozoroa Insignis |
| Ipni Id | 70169-1 |
| Plant Name | Ozoroa Insignis |
| Genus Tax Id | 289734 |
| Disease Name | Neuropathy, Otitis externa, Inborn purine/pyrimidine/nucleotide metabolism error, Solid tumour/cancer, Head and neck cancer, Mature T-cell lymphoma, Malignant digestive organ neoplasm, Acute myeloid leukaemia, Multiple myeloma, Liver cancer, Breast cancer, Irritable bowel syndrome, Pain, unspecified, Multiple sclerosis, Endometriosis, Cardiovascular disease, Diabetic foot ulcer, Otitis media, Breast in situ carcinoma, Vasomotor/allergic rhinitis, Pleomorphic sarcoma, Mature B-cell lymphoma, Myeloproliferative neoplasm, Substance abuse, Rheumatoid arthritis, Prostate cancer, Retinopathy, Transplanted organ/tissue, Nasopharyngeal cancer, Osteosarcoma, Blood-forming organ disease, Myelodysplastic syndrome, Stomach cancer, Gonococcal infection, Metastatic malignant neoplasm, Leiomyosarcoma, Diabetes mellitus, type unspecified, Pituitary gland disorder, Peritoneal cancer, Acne vulgaris, Inborn lipid metabolism error, Cervical cancer, Brain cancer, Acute diabete complication, Type 2 diabetes mellitus, BCR-ABL1-negative chronic myeloid leukaemia, Myocardial infarction, Bladder cancer, Coronary thrombosis, Lung cancer, Fallopian tube cancer, Urinary tract infection, Metastatic lymph node neoplasm, Bacterial infection, Chronic myelomonocytic leukaemia, Gastrointestinal stromal tumour, Chronic kidney disease, Unspecified viral infection of unspecified site, Male infertility, Motor neuron disease, Deep vein thrombosis, Lupus erythematosus, Digestive organ benign neoplasm, Parkinsonism, Hyperlipidemia, Endometrial cancer, Acute respiratory distress syndrome, Autoimmune disease, Colorectal cancer, Metastatic biliary tract neoplasms, Encephalopathy, Phakomatoses/hamartoneoplastic syndrome, Crohn disease, Transplant rejection, Psoriasis, Follicular lymphoma, Non-small cell lung cancer, Postoperative inflammation, Non-alcoholic fatty liver disease, Coagulation defect, Thrombocytopenia, Urethral cancer, Angina pectoris, Renal cell carcinoma, Lip/oral cavity/pharynx neoplasm, Hyper-lipoproteinaemia, Oesophageal/gastroduodenal disorder, Cerebral ischaemia, Influenza, Malignant haematopoietic neoplasm, Chemoprotection, Carcinoid syndrome, Skin postprocedural disorder, Glaucoma, Herpes simplex infection, Anogenital warts, Respiratory system disease, Parasitic worm infestation, Chronic pain, Chronic arterial occlusive disease, Oesophagitis, Autism spectrum disorder, Cushing syndrome, Fragile X chromosome, Fungal infection, Diffuse large B-cell lymphoma, Alzheimer disease, Menopausal disorder, Indeterminate colitis, Coronavirus infection, Dementia, Thyroid cancer, Unspecific substance harmful effect, Vaginitis, Hypopharyngeal cancer, HIV-infected patients with tuberculosis, Melanoma, Mastocytosis, Choreiform disorder, Pancreatic cancer, Liver disease, Schizophrenia, Malignant mesenchymal neoplasm, Obesity, Synovial sarcoma, Type-1/2 diabete, Ovarian cancer, Metabolic disorder, Nutritional deficiency, Ischemia, Colon cancer, Pulmonary hypertension, Testicular cancer, Synthesis disorder, Mature B-cell leukaemia, Asthma, Cerebral ischaemic stroke, Thrombosis, Sepsis, Unspecific body region injury, Liposarcoma, Intracerebral haemorrhage, Acquired prion disease, Bleeding disorder, Metastatic digestive system neoplasm, Biliary tract cancer, Thyrotoxicosis, Idiopathic interstitial pneumonitis, Venous thromboembolism, Spinal cord/cranial nerve neoplasm, Human immunodeficiency virus disease, Atopic eczema, Metastatic liver/bile duct neoplasm, Prostate hyperplasia, Ischaemic/haemorrhagic stroke, Pediculosis, Muscular dystrophy, Acute/subacute hepatic failure, Female pelvic pain, Adrenal cancer, Myotonic disorder, Gout, Autonomic nervous system disorder, Mineral deficiency, Inflammatory arthropathy, Seborrhoeic dermatitis, Female genital tract noninflammatory disorder, Attention deficit hyperactivity disorder, Mild neurocognitive disorder, Heart failure, Adrenomedullary hyperfunction, Cataract, Kaposi sarcoma, Dyspareunia, Esophageal cancer, Extraocular muscle disorder, Skeletal anomaly, Hepatitis virus infection, Ophthalmic devices/implants/grafts injury, Female infertility, Kidney failure, Epidermal dysplasias, Bone/articular cartilage neoplasm, Skin and skin-structure infection, Ischemic heart disease, Multiple structural anomalies syndrome, Dyslipidemia, Peroxisomal disease, Syphilis, Filariasis, Lysosomal disease, Low bone mass disorder, Supraventricular tachyarrhythmia, Myasthenia gravis, Ocular cancer, Menstrual cycle bleeding disorder, Common warts, Christmas disease, Metastatic tumour, Ovarian dysfunction, Psychotic disorder, Acute pancreatitis, Hypotension, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Maternal care for signs of fetal hypoxia, Chronic hepatitis C, Structural developmental anomaly of heart or great vessels, unspecified, Malignant neoplasms of other or unspecified parts of mouth, Dysplastic naevus, Cystic fibrosis, Constipation, Chronic obstructive pulmonary disease, coronary artery disease, Allergic conjunctivitis, Diabetic polyneuropathy, COVID-19, Wheezing, Malaria, Osteoarthritis, Kidney failure, unspecified, Septic shock, Ageing associated decline in intrinsic capacity, Pulpitis, Central nervous system disease, Bronchiectasis, Adenocarcinoma of prostate, Single episode depressive disorder, severe, without psychotic symptoms, Premenstrual tension syndrome, Nephrocalcinosis, Hearing disorder, Oligodendroglioma, anaplastic, Cerebral oedema, Malignant neoplasms of kidney, except renal pelvis, Other specified increased intracranial pressure, Unspecified malignant neoplasms of unspecified sites, Obstructive sleep apnoea, Glioma, malignant, Lichen planus, Gastro-oesophageal reflux disease, Congenital aplastic anaemia, Opioid use disorder, Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source, Tension-type headache, Chronic myeloid leukaemia, NOS, Allergic/hypersensitivity disorder, Glioblastoma, primary, NOS, Diseases of the visual system, unspecified, Macular degeneration, Postherpetic polyneuropathy, Intracranial injury, unspecified, Bacterial meningitis, Cholelithiasis, Primary sclerosing cholangitis, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Idiopathic pulmonary fibrosis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Malignant neoplasms of bladder, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Chronic rhinosinusitis, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Polycystic ovary syndrome, Dilated cardiomyopathy, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland, Malignant neoplasm of pancreas, Lyme borreliosis, Gliomas of brain |
| Species Name | Ozoroa insignis |
| Genus Name | Ozoroa |
| Species Tax Id | 289735 |
| Disease Id | 8C0Z, AA00-AA13, 5C55, 2A00-2F9Z, 2D42, 2A90, 2C11, 2A60, 2A83, 2C12, 2C60-2C6Y, DD91, MG3Z, 8A40, GA10, BA00-BE2Z, BD54, AA80-AB0Z, 2.00E+65, CA08, 2B54, 2A85, 2A20, 6C40, FA20, 2C82, 9B71, QB63, 2B6B, 2B51, 3C0Z, 2A37, 2B72, 1A70-1A7Z, 2D50-2E09, 2B58, 5A14, 5A60-5A61, 2C51, ED80, 5C52, 2C77, 2A00, 5A2Y, 5A11, 2A41, BA41-BA43, 2C94, BA43, 2C25, 2C74, GC08, 2D60, 1A00-1C4Z, 2A40, 2B5B, GB61, 1D9Z, GB04, 8B60, BD71, 4A40, 2.00E+92, 8A00, 5C80, 2C76, CB00, 4A40-4A45, 2B91, 2C14-2C17, 8.00E+47, LD2D, DD70, NE84, EA90, 2A80, 1A00-CA43, DB92, 3B10, 3B64, 2C93, BA40, 2C90, 2B6E, DD90, 8B1Z, 1E30-1E32, 2B33, N.A., 5B10, EL8Y, 9C61, 1F00, 1A95, CB40-CB7Z, 1F90, MG30, BD4Z, DA24, 6A02, 5A70, LD55, 1F29-1F2F, 2A81, 8A20, GA30, DD72, 1D92, 6D80-6D8Z, 2D10, NE6Z, GA02, 2B6D, 1B10-1B14, 2C30, 2A21, 8A01, 2C10, DB90-DB9Z, 6A20, 2B5D-2B5Y, 5B80-5B81, 2B5A, 5A10-5A11, 2C73, 5C50-5D2Z, 5B50-5B71, 8B10-8B11, 2B90, BB01, 2C80, 5C52-5C59, 2A82, CA23, 8B11, DB61-GB90, 1G40-1G41, ND56, 2B59, 8B00, 8.00E+01, GA20-GA21, 2D8Y, 2C17, 5A02, CB03, BD72, 2A02, 1C60-1C62, EA80, 2D80, GA90, 8B20, 1G00, 8C70, DB91, GA34, 2D11, 8C71, FA25, 8D87, 5B5K, FA2Z, EA81, GA1Y, 6A05, 6D71, BD10-BD1Z, 5A75, 9B10, 2B57, GA12, 2B70, 9C82, LD24, 1E50-1E51, PK97, GA31, GB60-GB6Z, EK90, 2F7B, 1F28-1G0Z, BA40-BA6Z, LD2F, 5C80-5C81, 5C57, 1A61-1A6Z, 1F66, 5C56, FB83, BC81, 8C6Y, 2D00-2D07, GA20, 1.00E+80, 3B11, 2D50-2E2Z, 5A80, 6A20-6A25, DC31, BA20-BA21, 1C62.Z, JA86.2, 1E51.1, LA8Z, 2B66, XH9035, CA25, ME05.0, CA22, BA8Y-BA8Z, 9A60.02, 8C03.0, 1D6Y, MD11.C, 1F40-1F45, FA00-FA05, GB6Z, XS26, MG2A, DA09.0, 8A04-8D87, CA24, 2C82.0, 6A70.3, GA34.40, GB57, AB50-AB57, XH8844, 8D60.1, 8D60.Y, 2D4Z, 7A41, XH4RQ3, EA91, DA22, 3A70.0, 6C43, PH56, 8A81, XH4XG8, 4A80-4A8Z, XH0MB1, 9E1Z, 9B75, 1E91.5, NA07.Z, 1D01.0, DC11, DB96.2, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 1D2Z, 2C15, 2C12.01, 1F54, CB03.4, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, 4A42, CA0A, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 5A80.1, BC43.0, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 1D60.01, 1C1G, 2A00.0 |
| Family Name | Anacardiaceae |
| Family Tax Id | 4011 |
- 1. (10r,11r)-10-[(14r,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 44584736)
- 2. (10r,11r)-10-[(14r,15s,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 153274273)
- 3. (10r,11r)-10-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 44567110)
- 4. (10r,11r)-10-[(14s,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,16,17,18,21,22,33,34-Undecahydroxy-9,24,31-Trioxaheptacyclo[24.8.0.02,7.014,19.020,29.023,28.027,32]tetratriaconta-1(34),2,4,6,14,16,18,20,22,26,28,32-Dodecaene-8,13,25,30-Tetrone (PubChem CID: 162883503)
- 5. (10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-Octahydroxy-13-(Hydroxymethyl)-9,12,16-Trioxatetracyclo[16.4.0.02,7.010,15]docosa-1(22),2,4,6,18,20-Hexaene-8,17-Dione (PubChem CID: 11754973)
- 6. (10s,11r,12s,13r,15s)-3,4,5,11,12,13,21,22,23,26,27,38,39-Tridecahydroxy-9,14,17,29,36-Pentaoxaoctacyclo[29.8.0.02,7.010,15.019,24.025,34.028,33.032,37]nonatriaconta-1(39),2,4,6,19,21,23,25,27,31,33,37-Dodecaene-8,18,30,35-Tetrone (PubChem CID: 162917712)
- 7. (10s,11s,13s,47r,48s)-3,4,5,11,19,20,21,24,25,36,37,40,41,42,52,53,54-Heptadecahydroxy-9,12,15,27,34,46,49-Heptaoxaundecacyclo[49.3.1.02,7.010,48.013,47.017,22.023,32.026,31.029,38.030,35.039,44]pentapentaconta-1(55),2,4,6,17,19,21,23,25,29,31,35,37,39,41,43,51,53-Octadecaene-8,16,28,33,45,50-Hexone (PubChem CID: 163040145)
- 8. (1r,2s,4as,6ar,6as,6bs,8as,10s,12ar,14br)-10-Hydroxy-1,2,6a,6b,9,9,12a-Heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 162948465)
- 9. (1r,2s,8r,10r,19r,20s,39s)-8,9,9,13,14,25,26,27,30,31,32,39-Dodecahydroxy-3,18,21,36,38,40-Hexaoxaoctacyclo[18.17.1.12,19.18,12.05,10.011,16.023,28.029,34]tetraconta-5,11,13,15,23,25,27,29,31,33-Decaene-4,7,17,22,35-Pentone (PubChem CID: 163060266)
- 10. (1r,35r,37r,38r,55s)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-Heptadecahydroxy-2,14,21,33,36,39,54-Heptaoxaundecacyclo[33.20.0.04,9.010,19.013,18.016,25.017,22.026,31.038,55.041,46.047,52]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,41,43,45,47,49,51-Octadecaene-3,15,20,32,40,53-Hexone (PubChem CID: 16148440)
- 11. (1r,35r,37r,38s,39s)-6,7,8,11,12,23,24,27,28,29,37,38,39-Tridecahydroxy-2,14,21,33,36-Pentaoxaoctacyclo[33.2.2.04,9.010,19.013,18.016,25.017,22.026,31]nonatriaconta-4,6,8,10,12,16,18,22,24,26,28,30-Dodecaene-3,15,20,32-Tetrone (PubChem CID: 162852731)
- 12. (1r,35s,37r,38r,55s)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-Heptadecahydroxy-2,14,21,33,36,39,54-Heptaoxaundecacyclo[33.20.0.04,9.010,19.013,18.016,25.017,22.026,31.038,55.041,46.047,52]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,41,43,45,47,49,51-Octadecaene-3,15,20,32,40,53-Hexone (PubChem CID: 163000163)
- 13. (1s,2r,4as,6ar,6as,6br,8as,9r,10r,11r,12ar,14bs)-10,11-Dihydroxy-9-(Hydroxymethyl)-1,2,6a,6b,9,12a-Hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 51531959)
- 14. (1s,35r,36s,53r,54s)-6,7,8,11,12,23,24,27,28,29,41,42,43,46,47,48,54-Heptadecahydroxy-2,14,21,33,37,52,55-Heptaoxaundecacyclo[33.18.2.04,9.010,19.013,18.016,25.017,22.026,31.036,53.039,44.045,50]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,39,41,43,45,47,49-Octadecaene-3,15,20,32,38,51-Hexone (PubChem CID: 162934030)
- 15. (1s,37r,39s,40r,57r)-7,8,9,12,13,24,25,28,29,30,39,45,46,47,50,51,52-Heptadecahydroxy-2,3,15,22,34,35,38,41,56-Nonaoxaundecacyclo[35.20.0.05,10.011,20.014,19.017,26.018,23.027,32.040,57.043,48.049,54]heptapentaconta-5,7,9,11,13,17,19,23,25,27,29,31,43,45,47,49,51,53-Octadecaene-4,16,21,33,42,55-Hexone (PubChem CID: 162935026)
- 16. (26r,27s,44r,45s,47r)-3,4,15,16,19,20,21,32,33,34,37,38,39,45,52,53,54-Heptadecahydroxy-6,13,25,28,43,46,49-Heptaoxaundecacyclo[49.3.1.02,11.05,10.08,17.09,14.018,23.026,47.027,44.030,35.036,41]pentapentaconta-1(55),2,4,8,10,14,16,18,20,22,30,32,34,36,38,40,51,53-Octadecaene-7,12,24,29,42,50-Hexone (PubChem CID: 163005441)
- 17. (2e,4e,8z,11z)-N-(2-Hydroxy-2-Methylpropyl)tetradeca-2,4,8,11-Tetraenamide (PubChem CID: 14135319)
- 18. (2r,3s)-3-[(10r,11s)-3,4,5,11,16,17,18-Heptahydroxy-8,14-Dioxo-9,13-Dioxatricyclo[13.3.1.02,7]nonadeca-1(19),2,4,6,15,17-Hexaen-10-Yl]-2,3-Bis[(3,4,5-Trihydroxybenzoyl)oxy]propanoic Acid (PubChem CID: 162963168)
- 19. (2r,3s,4s,5r,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-(2-Phenylethoxy)oxane-3,4,5-Triol (PubChem CID: 13893575)
- 20. (2r,3s,4s,5r,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3,5-Dimethoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 11386564)
- 21. (2s)-2,5,7-Trihydroxy-2-(4-Hydroxyphenyl)-4h-Chromen-3-One (PubChem CID: 162849938)
- 22. (2s)-2-(2,5-Dihydroxy-4-Methoxyphenyl)-5,6,8-Trihydroxy-7-[(2s,3r,4s,5r)-3,4,5-Trihydroxyoxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 162895369)
- 23. (2s)-5,6,7,8-Tetrahydroxy-2-(2,3,5-Trihydroxy-4-Methoxyphenyl)-2,3-Dihydrochromen-4-One (PubChem CID: 162926145)
- 24. (2s)-7-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5s)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-3,4,5-Trihydroxyoxan-2-Yl]oxy-2-(3,4-Dihydroxyphenyl)-5-Hydroxy-2,3-Dihydrochromen-4-One (PubChem CID: 163016799)
- 25. (2s)-7-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5s)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-3,4,5-Trihydroxyoxan-2-Yl]oxy-5-Hydroxy-2-(4-Methoxyphenyl)-2,3-Dihydrochromen-4-One (PubChem CID: 162845747)
- 26. (2s,3s,4s,5s,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3,5-Dimethoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 162923232)
- 27. (2s,3s,4s,5s,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3-Methoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 162981462)
- 28. (3r,3ar,4r,6r,6as)-3,6-Bis(1,3-Benzodioxol-5-Yl)-1,3,3a,4,6,6a-Hexahydrofuro[3,4-C]furan-4-Ol (PubChem CID: 162932626)
- 29. (3r,8r,9r,10s,13r,14r,17s)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 162965363)
- 30. (4as,6as,6as,6br,8ar,12as,14bs)-12a-(Hydroxymethyl)-2,2,6a,6b,9,9-Hexamethyl-10-Oxo-3,4,5,6,6a,7,8,8a,13,14b-Decahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 163075661)
- 31. (4as,6as,6as,6br,8ar,12r,12ar,14bs)-12-Hydroxy-2,2,6a,6b,9,9,12a-Heptamethyl-10-Oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-Dodecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 15765604)
- 32. (8s,9s,13s,14r)-3-Hydroxy-13-Methyl-7,8,9,11,12,14,15,16-Octahydro-6h-Cyclopenta[A]phenanthren-17-One (PubChem CID: 670995)
- 33. (E,1s,8r,10s,11s)-4,8-Dimethyl-1-[(1r,2s)-2,6,6-Trimethylcyclohex-3-En-1-Yl]tridec-3-Ene-1,8,10,11-Tetrol (PubChem CID: 162948211)
- 34. 1,2,3-Tri-O-Galloyl-Beta-D-Glucose (PubChem CID: 5322038)
- 35. 1,2,4,6-Tetra-O-Galloyl-Beta-D-Glucose (PubChem CID: 11297287)
- 36. 1,2,4-Tri-O-Galloyl-Beta-Glucopyranose (PubChem CID: 88204715)
- 37. 1,2,6-Trigalloylglucose (PubChem CID: 440308)
- 38. 1,3,4-Tri-O-Galloyl-Beta-Glucopyranose (PubChem CID: 16066749)
- 39. 1,4,6-Tri-O-Galloyl-Beta-D-Glucose (PubChem CID: 10077822)
- 40. 1-[(2r)-Piperidin-2-Yl]propan-2-One (PubChem CID: 3034881)
- 41. 1-[(2s)-1-Methylpiperidin-2-Yl]propan-2-One (PubChem CID: 820378)
- 42. 1-Desgalloyleugeniin (PubChem CID: 9918701)
- 43. 13-Hydroxy-12-Methoxy-3,5,10,17-Tetraoxapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2(6),7,11(19),12,14-Hexaene-9,16-Dione (PubChem CID: 10336592)
- 44. 2''-O-Galloylquercitrin (PubChem CID: 10031482)
- 45. 2,3,8-Tri-O-Methylellagic Acid (PubChem CID: 5281860)
- 46. 2-[3-[[(1r,5s)-6,6-Dimethyl-2-Bicyclo[3.1.1]hept-2-Enyl]methyl]-4-Hydroxyphenyl]-3,7,8-Trihydroxychromen-4-One (PubChem CID: 162983852)
- 47. 24-Hydroxyursolic Acid (PubChem CID: 44568920)
- 48. 3,3'-Di-O-Methylellagic Acid (PubChem CID: 5488919)
- 49. 3,3a(2),4a(2)-Tri-O-Methylellagic Acid (PubChem CID: 11674590)
- 50. 3-(Hydroxymethylidene)pyran-4-One (PubChem CID: 101406579)
- 51. 3-O-Methylellagic Acid (PubChem CID: 13915428)
- 52. 3-O-Methylellagic Acid 4-O-Rhamnoside (PubChem CID: 16720461)
- 53. 5,7-Dihydroxy-2-[4-Hydroxy-3-[(2s,3r,4s,5r)-3,4,5-Trihydroxyoxan-2-Yl]oxyphenyl]chromen-4-One (PubChem CID: 101675298)
- 54. 5-Desgalloylstachyurin (PubChem CID: 10417809)
- 55. 6-[(E)-Prop-1-Enyl]-2,3,4,5-Tetrahydropyridine (PubChem CID: 15937508)
- 56. 6-[[(2r,3s,4s,5r,6s)-6-[(2s,3r,4s,5r,6s)-4,5-Dihydroxy-2-Methyl-6-[(7,13,14-Trihydroxy-3,10-Dioxo-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaen-6-Yl)oxy]oxan-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methoxy]-7,13,14-Trihydroxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 11968423)
- 57. 6-[[(2r,3s,4s,5r,6s)-6-[(2s,3r,4s,5s,6r)-4,5-Dihydroxy-2-Methyl-6-[(7,13,14-Trihydroxy-3,10-Dioxo-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaen-6-Yl)oxy]oxan-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methoxy]-7,13,14-Trihydroxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 163005628)
- 58. 6-Prop-1-Enyl-2,3,4,5-Tetrahydropyridine (PubChem CID: 76453742)
- 59. 7,8,9-Trihydroxy-1,2-Dihydrocyclopenta[C]isochromene-3,5-Dione (PubChem CID: 10131135)
- 60. 7-Hydroxy-6,14-Dimethoxy-13-[(2s,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 162978332)
- 61. 8-O-[(1r,19r,21r,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 1-O-Methyl (1r,3ar,8br)-5,6-Dihydroxy-3a-(2-Methoxy-2-Oxoethyl)-3-Oxo-1,8b-Dihydrofuro[3,4-B][1]benzofuran-1,8-Dicarboxylate (PubChem CID: 71475292)
- 62. 8-O-[(1r,19r,21r,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 1-O-Methyl (1s,3ar,8br)-5,6-Dihydroxy-3a-(2-Methoxy-2-Oxoethyl)-3-Oxo-1,8b-Dihydrofuro[3,4-B][1]benzofuran-1,8-Dicarboxylate (PubChem CID: 163009667)
- 63. [(10r,11r)-10-[(14r,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,16,17,18,21,22,33,34-Decahydroxy-8,13,25,30-Tetraoxo-9,24,31-Trioxaheptacyclo[24.8.0.02,7.014,19.020,29.023,28.027,32]tetratriaconta-1(34),2,4,6,14,16,18,20,22,26,28,32-Dodecaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163006263)
- 64. [(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-Octahydroxy-8,17-Dioxo-9,12,16-Trioxatetracyclo[16.4.0.02,7.010,15]docosa-1(22),2,4,6,18,20-Hexaen-13-Yl]methyl 3,4,5-Trihydroxybenzoate (PubChem CID: 14428069)
- 65. [(10r,11s)-10-[(14r,15s,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,17,18,19-Hexahydroxy-8,14-Dioxo-9,13-Dioxatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-Hexaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 17999934)
- 66. [(10r,11s)-3,4,5,17,18,19,22,23,34,35-Decahydroxy-10,11-Dimethyl-8,14,26,31-Tetraoxo-10-[(1s)-1-[(3r,4r)-4,5,6,7-Tetrahydroxy-3-Methyl-1-Oxo-4h-Isochromen-3-Yl]-1-(3,4,5-Trihydroxybenzoyl)oxyethyl]-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162851938)
- 67. [(10r,11s,12r,13s,15s)-3,4,5,11,21,22,23-Heptahydroxy-8,18-Dioxo-13-(3,4,5-Trihydroxybenzoyl)oxy-9,14,17-Trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-Hexaen-12-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162959404)
- 68. [(10s,11s,12r,13s,15r)-3,4,5,11,13,21,22,23,26,27,38,39-Dodecahydroxy-8,18,30,35-Tetraoxo-9,14,17,29,36-Pentaoxaoctacyclo[29.8.0.02,7.010,15.019,24.025,34.028,33.032,37]nonatriaconta-1(39),2,4,6,19,21,23,25,27,31,33,37-Dodecaen-12-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163048086)
- 69. [(10s,11s,12s,13r,15r)-3,4,5,12,21,22,23-Heptahydroxy-8,18-Dioxo-13-(3,4,5-Trihydroxybenzoyl)oxy-9,14,17-Trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-Hexaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163086347)
- 70. [(1r,19r,21s,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 14411426)
- 71. [(1r,2s)-1-[(14r,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994710)
- 72. [(1r,2s)-1-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994708)
- 73. [(1s,19r,21s,22r,23r)-5,6,7,8,11,12,13,14,22,23-Decahydroxy-3,16-Dioxo-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4(9),5,7,10(15),11,13-Hexaen-21-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163190909)
- 74. [(1s,19r,21s,22r,23r)-5,6,7,8,11,12,13,14-Octahydroxy-3,16-Dioxo-21,22-Bis[(3,4,5-Trihydroxybenzoyl)oxy]-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4(9),5,7,10(15),11,13-Hexaen-23-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162857441)
- 75. [(1s,2s)-1-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994709)
- 76. [(2r)-2,3-Bis[[(9z,11e,13z)-Octadeca-9,11,13-Trienoyl]oxy]propyl] (9z,12z,14e)-Nonadeca-9,12,14-Trienoate (PubChem CID: 163025003)
- 77. [(2r)-2,3-Dihydroxypropyl] (9e,11z,13e)-Octadeca-9,11,13-Trienoate (PubChem CID: 163082131)
- 78. [(2r)-2-Hydroxy-3-(3-Methylbutoxy)propyl] Octadec-2-Enoate (PubChem CID: 163029346)
- 79. [(2r,3r)-3-[(14s,15r,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-2,3-Dihydroxypropyl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163044145)
- 80. [(2r,3s,4s,5r,6s)-3,4,5,6-Tetrahydroxyoxan-2-Yl]methyl 3,4,5-Trihydroxybenzoate (PubChem CID: 11968480)
- 81. [(4r)-11-(3,5-Dihydroxyphenyl)undecan-4-Yl] 2,4-Dihydroxy-6-Undecylbenzoate (PubChem CID: 162880630)
- 82. [(4r)-4-Hydroxynon-6-Enyl] Benzoate (PubChem CID: 162870803)
- 83. Alpha-Pedunculagin (PubChem CID: 13834142)
- 84. Apigenin-4'-Glucoside (PubChem CID: 5491384)
- 85. Beta-Phenylethanol Beta-D-Rutinoside (PubChem CID: 11166301)
- 86. Beta-Sitosterol (PubChem CID: 222284)
- 87. Beta-Sitosteryl Acetate (PubChem CID: 5354503)
- 88. Betulin (PubChem CID: 72326)
- 89. Betulinic Acid (PubChem CID: 64971)
- 90. Borneol (PubChem CID: 6552009)
- 91. Cid 3003153 (PubChem CID: 3003153)
- 92. Cid 5464368 (PubChem CID: 5464368)
- 93. Corilagin (PubChem CID: 73568)
- 94. Cyanidin (PubChem CID: 128861)
- 95. Cyclo(L-Pro-L-Val) (PubChem CID: 6992261)
- 96. Delphinidin 3,5-Diglucoside (PubChem CID: 10100906)
- 97. Ellagic Acid (PubChem CID: 5281855)
- 98. Epicatechin (PubChem CID: 72276)
- 99. Epifriedelin (PubChem CID: 15559350)
- 100. Eschweilenol C (PubChem CID: 10026656)
- 101. Estrone (PubChem CID: 5870)
- 102. Ethyl (1r)-7,8,9-Trihydroxy-3,5-Dioxo-1,2-Dihydrocyclopenta[C]isochromene-1-Carboxylate (PubChem CID: 162850267)
- 103. Ethyl (6r)-4-(2-Ethoxy-2-Oxoethyl)-11,12-Dihydroxy-3,8-Dioxo-2,7-Dioxatricyclo[7.3.1.05,13]trideca-1(13),4,9,11-Tetraene-6-Carboxylate (PubChem CID: 162942104)
- 104. Flavogallonic Acid (PubChem CID: 14503023)
- 105. Flavylium, 3,3',4',5,5',7-Hexahydroxy- (PubChem CID: 128853)
- 106. Friedelin (PubChem CID: 91472)
- 107. Galactitol (PubChem CID: 11850)
- 108. Gallagic Acid (PubChem CID: 14754405)
- 109. Gallic Acid (PubChem CID: 370)
- 110. Galloyl(-4)glc(B1-6)glc(B)-O-Galloyl (PubChem CID: 162844808)
- 111. Glc(B1-4)glc(B1-4)glc(B1-4)glc6me(B1-4)a-Rha (PubChem CID: 162975384)
- 112. Glycerin (PubChem CID: 753)
- 113. Granatan-3-One (PubChem CID: 6602484)
- 114. Hydroxy-Alpha-Sanshool (PubChem CID: 10084135)
- 115. Hydroxy-Gamma-Isosanshool (PubChem CID: 14135316)
- 116. Hyperoside (PubChem CID: 5281643)
- 117. I(2)-D-Glucopyranoside, (2e)-3-(4-Hydroxy-3-Methoxyphenyl)-2-Propenyl 6-O-D-Apio-I(2)-D-Furanosyl (PubChem CID: 11408873)
- 118. Kanugin (PubChem CID: 12305452)
- 119. Linalool, (+)- (PubChem CID: 67179)
- 120. Lupeol (PubChem CID: 259846)
- 121. Luteolin (PubChem CID: 5280445)
- 122. Luteolin-4'-O-Glucoside (PubChem CID: 5319116)
- 123. Mannitol (PubChem CID: 6251)
- 124. Maslinic Acid (PubChem CID: 73659)
- 125. Methyl (1s,2s,6s,7s,8r,11s,14s,15r,18r,20s)-20-Hydroxy-7,8,14,15,19,19-Hexamethyl-21-Oxahexacyclo[18.2.2.01,18.02,15.05,14.06,11]tetracos-4-Ene-11-Carboxylate (PubChem CID: 163010693)
- 126. Methyl Gallate (PubChem CID: 7428)
- 127. Morusignin J (PubChem CID: 71452951)
- 128. Myricetin (PubChem CID: 5281672)
- 129. N-Methylpelletierine (PubChem CID: 1548928)
- 130. N-Trans-Feruloyltramine (PubChem CID: 5280537)
- 131. Oleanolic Acid (PubChem CID: 10494)
- 132. Oleic Acid (PubChem CID: 445639)
- 133. Palmitic Acid (PubChem CID: 985)
- 134. Pelargonin (PubChem CID: 441772)
- 135. Pentagalloylglucose (PubChem CID: 65238)
- 136. Pinnatin (PubChem CID: 5320607)
- 137. Pregnenolone (PubChem CID: 8955)
- 138. Prosapogenin A (PubChem CID: 11061578)
- 139. Punicafolin (PubChem CID: 5320800)
- 140. Punicanolic Acid (PubChem CID: 25132490)
- 141. Punicic Acid (PubChem CID: 5281126)
- 142. Punigluconin (PubChem CID: 21637585)
- 143. Quercetin (PubChem CID: 5280343)
- 144. Rutin (PubChem CID: 5280805)
- 145. Sesamin, (-)- (PubChem CID: 382073)
- 146. Sitogluside (PubChem CID: 5742590)
- 147. Stigmasterol (PubChem CID: 5280794)
- 148. Strictinin (PubChem CID: 73330)
- 149. Tricetin (PubChem CID: 5281701)
- 150. Ursolic Acid (PubChem CID: 64945)
- 1. Alzheimer's Disease 1
- 2. Arthritis
- 3. Arthritis, Gouty
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Brain Edema
- 7. Bronchiectasis
- 8. Cardiovascular Diseases
- 9. Cataract
- 10. Celiac Disease
- 11. Chancre
- 12. Cholelithiasis
- 13. Cholera
- 14. Common Wart
- 15. Constipation
- 16. Coronary Artery Disease
- 17. Crohn Disease
- 18. Cystic Fibrosis
- 19. Dementia
- 20. Diabetes Mellitus
- 21. Diabetes Mellitus, Type 1
- 22. Esophagitis
- 23. Female Infertility Of Uterine Origin
- 24. Filariasis
- 25. Glaucoma
- 26. Gonorrhea
- 27. Hematologic Diseases
- 28. Infertility, Male
- 29. Inflammatory Bowel Diseases
- 30. Influenza, Human
- 31. Liver Neoplasms
- 32. Lupus Erythematosus, Systemic
- 33. Muscular Dystrophies
- 34. Myocardial Infarction
- 35. Neoplasms
- 36. Obesity
- 37. Osteoarthritis
- 38. Pre-Eclampsia
- 39. Psoriasis
- 40. Psychotic Disorder
- 41. Scleroderma, Systemic
- 42. Thrombocytopenia
- 43. Urinary Tract Infections
- 44. Vaginitis
Not listed in any formulations.